Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Bone marrow failure and the telomeropathies.

Townsley DM, Dumitriu B, Young NS.

Blood. 2014 Oct 30;124(18):2775-83. doi: 10.1182/blood-2014-05-526285. Epub 2014 Sep 18. Review.

PMID:
25237198
2.

Human dyskerin: beyond telomeres.

Angrisani A, Vicidomini R, Turano M, Furia M.

Biol Chem. 2014 Jun;395(6):593-610. doi: 10.1515/hsz-2013-0287. Review.

PMID:
24468621
3.

The genetics of dyskeratosis congenita.

Mason PJ, Bessler M.

Cancer Genet. 2011 Dec;204(12):635-45. doi: 10.1016/j.cancergen.2011.11.002. Review.

4.

Dyskeratosis congenita.

Dokal I.

Hematology Am Soc Hematol Educ Program. 2011;2011:480-6. doi: 10.1182/asheducation-2011.1.480. Review.

5.

Dyskeratosis congenita as a disorder of telomere maintenance.

Nelson ND, Bertuch AA.

Mutat Res. 2012 Feb 1;730(1-2):43-51. doi: 10.1016/j.mrfmmm.2011.06.008. Epub 2011 Jul 2. Review.

6.

Dermatological manifestations of inherited cancer syndromes in children.

Karalis A, Tischkowitz M, Millington GW.

Br J Dermatol. 2011 Feb;164(2):245-56. doi: 10.1111/j.1365-2133.2010.10100.x. Review.

PMID:
20973772
7.

[Bone marrow failure due to telomere associated gene mutation].

Yamaguchi H, Dan K.

Rinsho Ketsueki. 2010 Aug;51(8):646-53. Review. Japanese. No abstract available.

PMID:
20805671
8.

Dyskeratosis congenita.

Gupta V, Kumar A.

Adv Exp Med Biol. 2010;685:215-9. Review.

PMID:
20687509
9.

Dyskeratosis congenita: clinical report and review of the literature.

Baran I, Nalcaci R, Kocak M.

Int J Dent Hyg. 2010 Feb;8(1):68-74. doi: 10.1111/j.1601-5037.2009.00364.x. Review.

PMID:
20096085
10.

Dyskeratosis congenita, stem cells and telomeres.

Kirwan M, Dokal I.

Biochim Biophys Acta. 2009 Apr;1792(4):371-9. doi: 10.1016/j.bbadis.2009.01.010. Epub 2009 Feb 7. Review.

11.

Dyskerin, telomerase and the DNA damage response.

Gu B, Bessler M, Mason PJ.

Cell Cycle. 2009 Jan 1;8(1):6-10. Epub 2009 Jan 24. Review.

12.

Nucleolus, ribosomes, and cancer.

Montanaro L, Treré D, Derenzini M.

Am J Pathol. 2008 Aug;173(2):301-10. doi: 10.2353/ajpath.2008.070752. Epub 2008 Jun 26. Review.

13.

Dyskeratosis congenita: a genetic disorder of many faces.

Kirwan M, Dokal I.

Clin Genet. 2008 Feb;73(2):103-12. Epub 2007 Nov 14. Review.

PMID:
18005359
14.

Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.

Vulliamy TJ, Dokal I.

Biochimie. 2008 Jan;90(1):122-30. Epub 2007 Jul 31. Review.

PMID:
17825470
15.

Dyskeratosis congenita.

Vulliamy T, Dokal I.

Semin Hematol. 2006 Jul;43(3):157-66. Review.

PMID:
16822458
16.

X-chromosome inactivation: role in skin disease expression.

Happle R.

Acta Paediatr Suppl. 2006 Apr;95(451):16-23. Review.

PMID:
16720460
17.

Dyskeratosis congenita: a disorder of defective telomere maintenance?

Walne AJ, Marrone A, Dokal I.

Int J Hematol. 2005 Oct;82(3):184-9. Review.

PMID:
16207588
18.

Dyskeratosis congenita.

Handley TP, McCaul JA, Ogden GR.

Oral Oncol. 2006 Apr;42(4):331-6. Epub 2005 Sep 2. Review.

PMID:
16140563
19.

Dyskeratosis congenita: telomerase, telomeres and anticipation.

Marrone A, Walne A, Dokal I.

Curr Opin Genet Dev. 2005 Jun;15(3):249-57. Review.

PMID:
15917199
20.

Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer.

Marrone A, Dokal I.

Expert Rev Mol Med. 2004 Dec 20;6(26):1-23. Review.

PMID:
15613268
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk